Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
65.14
+0.42 (0.65%)
Aug 13, 2025, 4:00 PM - Market closed
Mirum Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 9 professional analysts, the 12-month price target for Mirum Pharmaceuticals stock ranges from a low of $49 to a high of $89. The average analyst price target of $73.89 forecasts a 13.43% increase in the stock price over the next year.
Price Target: $73.89 (+13.43%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Mirum Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Buy | 7 | 7 | 7 | 7 | 7 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 12 | 12 | 12 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Initiates $89 | Strong Buy | Initiates | $89 | +36.63% | Aug 11, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $77 → $89 | Buy | Maintains | $77 → $89 | +36.63% | Aug 8, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $79 → $81 | Buy | Maintains | $79 → $81 | +24.35% | Aug 7, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $77 → $82 | Strong Buy | Maintains | $77 → $82 | +25.88% | Aug 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $73 → $80 | Strong Buy | Maintains | $73 → $80 | +22.81% | Aug 7, 2025 |
Financial Forecast
Revenue This Year
460.74M
from 336.89M
Increased by 36.76%
Revenue Next Year
541.28M
from 460.74M
Increased by 17.48%
EPS This Year
-1.13
from -1.85
EPS Next Year
-0.50
from -1.13
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 489.7M | 597.0M | 711.3M | ||
| Avg | 460.7M | 541.3M | 644.3M | ||
| Low | 433.3M | 473.4M | 565.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 45.4% | 29.6% | 31.4% | ||
| Avg | 36.8% | 17.5% | 19.0% | ||
| Low | 28.6% | 2.7% | 4.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.58 | -0.03 | 0.88 | ||
| Avg | -1.13 | -0.50 | 0.54 | ||
| Low | -1.50 | -1.01 | -0.23 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.